Worth reading
44Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Announced details
SOKUYAKU (ソクヤク), an online medical consultation, medication guidance and prescription drug delivery service
Applicable field (uses covered by this announcement)
Online medical consultations, online prescription guidance, and patient information management and continued consultations at medical institutions
Launch dateAlready updated as of the announcement on 7 September 2026 (specific implementation date: Not disclosed)
What the company reported numerically
Quantitative Effects
Appointments for the next consultation can be booked up to 3 months in advance
Offering price
No registration fee or annual fee; the SOKUYAKU Premium plan costs ¥550 per month, including tax.
The company does not address Contract Value / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | SOKUYAKU (ソクヤク), an online medical consultation, medication guidance and prescription drug delivery service |
| Offering price | No registration fee or annual fee; the SOKUYAKU Premium plan costs ¥550 per month, including tax. |
| Launch date | Already updated as of the announcement on 7 September 2026 (specific implementation date: Not disclosed) |
| Applicable area | Online medical consultations, online prescription guidance, and patient information management and continued consultations at medical institutions |
| Quantitative Effects | Appointments for the next consultation can be booked up to 3 months in advance |
Items this document does not state (13)
CounterpartyCounterparty overviewRelationship with the CompanyContract ValueContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleUsage historyImpact on Business PerformanceSource
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To create ongoing engagement with patients who require regular consultations and make it easier for medical institutions to review and manage patient information.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.